期刊文献+

胱抑素C在冠心病危险分层的作用临床分析

Clinical analysis of cystatin C in the risk stratification of coronary artery disease
原文传递
导出
摘要 目的探讨冠状动脉粥样硬化性心脏病(CAD)患者血清胱抑素C(CysC)水平与其病变严重程度的关系。方法对194例行冠状动脉造影检查患者,根据结果分为冠心病组(102例)和对照组(非冠心病组92例),利用乳胶免疫增强比浊法检测两组患者血清CysC水平并进行比较。同时将患者按血清CysC水平〈0.67mg/L、≥0.67mg/L、≥0.89mg/L和〉1.00mg/L分为四组,比较各组的临床资料,明确血清CysC水平与冠心病及冠脉血管病变严重程度的关系。结果冠心病组血清CysC水平明显高于对照组(P〈0.05),随着血清CysC水平的升高,冠心病患者病情逐渐加重,冠状动脉病变严重程度评分增加;Logistic回归结果显示CysC是CAD发生的独立危险因子,与CAD病变程度相关;ROC曲线分析显示,取血清CysC水平0.79mg/L为临界值,预测的CAD发生的灵敏度和特异性分别为76.60%和82.60%。结论CysC是预测CAD发生的有价值的临床指标,血清CysC水平与冠心病有密切关系,随着血清CysC水平升高,冠心病患者病情逐渐加重。 Objective To evaluate the relationship of serum cystatin C (Cys C) levels and the severity of coronary artery diseases (CAD). Methods A total of 194 patients underwent coronary angiogra- phy were divided into two groups (102 CAD patients) and control group (non-CAD group, 92 cases) . To study the relationship of the level of serum cystatin C and the severity of CAD, the serum cystatin C of all enrolled patients was detected by immune-enhancing latex turbidimetry and the serum cystatin C level of CAD group was compared to control group. Results The serum levels of cystatin C of CAD were signifi- cantly higher than the control group ( P 〈 0.05). With the increased levels of serum Cys C, CAD severity average score was increased; logistic regression analysis showed that Cys C was one of the risk factors of CAD. Cystatin C concentration was significantly correlated with CAD severity score. A cut-off value of 0.79 mg/L for cystatin C predicted incident CAD with a sensitivity of 76.60% and specificity of 82.60%, respectively. Conclusions Serum Cys C levels are valuable clinical predictors and closely related to CAD. With the increasing levels of serum Cys C, CAD becomes more severe.
作者 郭纯 谭超超
出处 《中国医师杂志》 CAS 2012年第12期1609-1611,共3页 Journal of Chinese Physician
关键词 西司他汀类 血液 冠状动脉疾病 血液 冠状动脉疾病 病因学 Cystatins/blood Coronary artery disease/blood Coronary artery disease/etiology
  • 相关文献

参考文献8

  • 1唐莹,郝志新.冠心病、脑梗死患者血浆同型半胱氨酸浓度变化及相关研究[J].医学临床研究,2007,24(7):1153-1154. 被引量:4
  • 2彭雯,张湖萍,文晖,成蓓.不稳定型心绞痛患者血清同型半胱氨酸含量的变化[J].医学临床研究,2007,24(9):1546-1548. 被引量:1
  • 3GarcaAcua JM, Gonzdez Babarro E, Grigorian Shamagian L, et al. Cystatin C provides more information than other renal function parameters for stratifying risk in patients with acute coronary syndrome. Rev Esp Cardiol, 2009, 62(5) :510-519. 被引量:1
  • 4Luc G, Bard JM, Lesueur C, et al. Plasma cystatin C and development of coronary, heart disease:The PRIME Study. Athernselerosis, 2006,85 ( 2 ) :375-380. 被引量:1
  • 5Shlipak MG, Katz R, Fried LF,et al. Cystatin C and mortality in elderly persons with heart failure. J Am Coil Cardiol, 2005, 45 ( 2 ) : 268-271. 被引量:1
  • 6Lassus J, Harjola VP, Sund R, et al. Prognostic value of Cystatin- C in acute heart failure ill relaliun to other markers of renal function and NT-proBNP. Ear Heart J , 2007, 28(15) :1841-1847. 被引量:1
  • 7Kiyosue A, Hirata Y, Ando J, et al. Plasma Cystatin C Concentration Reflects the Severity of Coronary Artery Disease in Patients Without Chronic Kidney Disease. Circulation, 2010, 74 ( 11 ) : 2441 - 2447. 被引量:1
  • 8Ix JH, Shlipak MG, Chertow GM, et al. Association of cystatiu C with mortality,cardiovascular events, and ineldent heart failure among persons with coronary heart disease. Circulation, 2007, 115 (2) : 173-179. 被引量:1

二级参考文献10

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部